Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 1/20 | 0.63 |
| ▸ | PSMB5 | P28074 | 2/20 | 0.48 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 1/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | BACE1 | P56817 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylamine SCHEMBL28884788 | 0.96 | ESR2 (0.59) | ESR2PSMB5HDAC7ELANECYP2A6 | |
| SCHEMBL8679278 | 0.89 | ESR2 (0.52) | ESR2PSMB5HDAC7ELANECYP2A6 | |
| Thiophene SCHEMBL29291049 | 0.88 | ESR2 (0.52) | ESR2PSMB5HDAC7ELANECYP2A6 | |
| Formic Acid SCHEMBL28903029 | 0.88 | ESR2 (0.56) | ESR2PSMB5HDAC7ELANEMAOB | |
| SCHEMBL8029343 | 0.88 | ESR2 (0.52) | ESR2PSMB5HDAC7ELANECYP2A6 | |
| SCHEMBL28695736 | 0.88 | ESR2 (0.52) | ESR2PSMB5HDAC7ELANECYP2A6 | |
| Acetic Acid SCHEMBL449571 | 0.88 | ESR2 (0.56) | ESR2PSMB5HDAC7ELANEMAOB | |
| Piperazine SCHEMBL27262997 | 0.88 | ESR2 (0.52) | ESR2PSMB5HDAC7MAOBMAPT | |
| SCHEMBL30196173 | 0.86 | ESR2 (0.47) | ESR2ELANECYP2A6CYP2B6MAOB | |
| SCHEMBL284409 | 0.85 | ESR2 (0.47) | ESR2ELANECYP2A6MAOBALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119841277-A | Aromatic hydrocarbon composition, hydrogen conjugate and use thereof | 中睿氢洁(山东)能源科技有限公司 | 2025-04-18 | — | — | CN | claimed |
| US-20250006900-A1 | ANODE MATERIAL, PREPARATION METHOD THEREOF, AND LITHIUM ION BATTERY | DINGYUAN NEW ENERGY TECHNOLOGY CO., LTD (CN) | 2025-01-02 | — | — | US | claimed |
| EP-4290606-A1 | NEGATIVE ELECTRODE MATERIAL AND PREPARATION METHOD THEREFOR, AND LITHIUM-ION BATTERY | BTR NEW MATERIAL GROUP CO., LTD. (CN) | 2023-12-13 | — | — | EP | claimed |
| WO-2023202189-A1 | NEGATIVE ELECTRODE MATERIAL AND PREPARATION METHOD THEREFOR, AND LITHIUM-ION BATTERY | 贝特瑞新材料集团股份有限公司 | 2023-10-26 | — | — | WO | claimed |
| CN-115637005-B | Polypropylene composite material with rigidity, toughness, heat resistance and high flame retardance | 常州瑞杰新材料科技有限公司 | 2023-08-25 | — | — | CN | claimed |
| CN-106715422-B | Indene derivative, preparation method and the pharmaceutical composition for being used to prevent or treat retinal disease comprising it as active constituent | 忠南大学校产学协力团 | 2019-11-19 | — | — | CN | claimed |
| US-10017433-B2 | Transalkylated cyclohexylbenzyl and biphenyl compounds | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2018-07-10 | — | — | US | claimed |
| US-20180050971-A1 | Transalkylated Cyclohexylbenzyl and Biphenyl Compounds | EXXONMOBIL CHEMICAL PATENTS INC. | 2018-02-22 | — | — | US | claimed |
| EP-3277649-A1 | TRANSALKYLATED CYCLOHEXYLBENZYL AND BIPHENYL COMPOUNDS | ExxonMobil Chemical Patents Inc. (US) | 2018-02-07 | — | — | EP | claimed |
| CN-106715422-A | Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient | 忠南大学校产学协力团 | 2017-05-24 | — | — | CN | claimed |
| WO-2016160084-A1 | TRANSALKYLATED CYCLOHEXYLBENZYL AND BIPHENYL COMPOUNDS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-10-06 | — | — | WO | claimed |
| EP-2970051-A1 | (METHYLCYCLOHEXYL)TOLUENE ISOMER MIXTURES, THEIR PRODUCTION AND THEIR USE IN THE MANUFACTURE OF PLASTICIZERS | ExxonMobil Chemical Patents Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014159100-A1 | (METHYLCYCLOHEXYL)TOLUENE ISOMER MIXTURES, THEIR PRODUCTION AND THEIR USE IN THE MANUFACTURE OF PLASTICIZERS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2014-10-02 | — | — | WO | claimed |
| US-20140275605-A1 | (Methylcyclohexyl)Toluene Isomer Mixtures,Their Production and Their Use in the Manufacture of Plasticizers | EXXONMOBIL CHEMICAL PATENTS INC. | 2014-09-18 | — | — | US | claimed |
| EP-1667958-A2 | MELANIN CONCENTRATING HORMONE ANTAGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 2006-06-14 | — | — | EP | claimed |
| WO-2005033063-A2 | MELANIN CONCENTRATING HORMONE ANTAGONISTS | THE PROCTER & GAMBLE COMPANY (US) | 2005-04-14 | — | — | WO | claimed |
| US-20050075324-A1 | Melanin concentrating hormone antagonists | THE PROCTER & GAMBLE COMPANY (US) | 2005-04-07 | — | — | US | claimed |
| CN-119841277-A | Aromatic hydrocarbon composition, hydrogen conjugate and use thereof | 中睿氢洁(山东)能源科技有限公司 | 2025-04-18 | — | — | CN | disclosed |
| US-4631204-A | DISSOLVING METAL SALT OF CARBOXYLIC ACID IN DIPHENYL ALKANE DERIVATIVE | FUJI PHOTO FILM CO., LTD. (JP) | 1986-12-23 | — | — | US | disclosed |
| US-4559242-A | FOR PRESSURE SENSITIVE RECORDING, TWO COATING SOLUTIONS CONTAININGAROMATIC CARBOXYLIC ACID METAL SALT | FUJI PHOTO FILM CO., LTD. (JP) | 1985-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140275605-A1 | (Methylcyclohexyl)Toluene Isomer Mixtures,Their Production and Their Use in the Manufacture of Plasticizers | DDT, CYP3A4, TERT | ESR2 1350/4885PSMB5 713/4885HDAC7 3423/4885 |
| US-20050075324-A1 | Melanin concentrating hormone antagonists | MCHR1, MCHR2, MC1R | ESR2 1314/4885PSMB5 1655/4885HDAC7 3268/4885 |
| US-10017433-B2 | Transalkylated cyclohexylbenzyl and biphenyl compounds | DDT, CYP2B6, AHR | ESR2 2228/4885PSMB5 562/4885HDAC7 2664/4885 |
| US-20180050971-A1 | Transalkylated Cyclohexylbenzyl and Biphenyl Compounds | DDT, CYP2B6, AHR | ESR2 2228/4885PSMB5 562/4885HDAC7 2664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.